Alphatec Holdings, Inc. (ATEC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Group 1 - The company has made significant progress in addressing previous concerns regarding capital deployment, financing, and EBITDA, ending the year with strong cash flows and EBITDA [1] - The first quarter has been volatile for many stocks, particularly in the SMID and small-cap sectors, with Alphatec experiencing similar challenges [2] - There is a notable opportunity within the Spine market, which is large, although the company is currently a small player [2]